Priya Shete, MD, MPH

ASSOC PROF IN RES-HCOMP

I am an Associate Professor of Medicine and Epidemiology based in the Division of Pulmonary and Critical Care Medicine at the University of California, San Francisco where my research has focused on improving access to and quality of tuberculosis (TB) care, and now COVID-19 care, for vulnerable populations. My research has highlighted the central importance of patient and health system barriers to quality of TB care in high burden settings. My portfolio leverages methods in implementation research, social epidemiology, modelling, and health economics that will allow us to better study and understand these barriers to care as well as to provide tools to support national TB programs and departments of public health with the design and implementation of interventions that curb these barriers. My research background is enhanced by my experience working with Global TB Programme of the World Health Organization. I have also served as a public health advisor for USAID with a focus on health system strengthening and with the California Department of Public Health and their team lead for modeling and analytics during the COVID-19 response. I also direct the UCSF Implementation Science Training Program. I serve as an attending physician on the Pulmonary Consult Service, in the Medical Intensive Care Unit, and in the Department of Public Health Tuberculosis Clinic at Zuckerberg San Francisco General Hospital.

Education
Certificate, 01/2019 - Implementation Science, University of California
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
MPH, 12/2018 - Health Policy and Management, University of California
06/2015 - Pulmonary and Critical Care Medicine Fellowship, University of California
06/2010 - Residency in Internal Medicine, University of California
M.D., 05/2007 - Medicine, Yale University School of Medicine
B.A., 05/2001 - Biophysics, Johns Hopkins University
Publications

  1. Amy S. Tang, Zinnia Dong, Meagan Lee, Matthew Murrill, Priya B. Shete, Susannah K. Graves. “Think. Test. Treat TB” in Action: An Innovative Primary Care and Public Health Partnership to Improve Tuberculosis Prevention and Care. NEJM Catalyst 2024. PMID:


  2. Hoover CM, Estus E, Kwan A, Raymond K, Sreedharan T, León T, Jain S, Shete PB. California's COVID-19 Vaccine Equity Policy: Cases, Hospitalizations, And Deaths Averted In Affected Communities. Health affairs (Project Hope) 2024. PMID: 38709962


  3. Nanyunja G, Kadota JL, Namale C, Hudson M, Nalugwa T, Turyahabwe S, Cattamanchi A, Katamba A, Muhumuza P, Shete PB. Feasibility of a social protection linkage program for individuals at-risk for tuberculosis in Uganda. PLOS Global Public Health 2023. PMID: 38064449


  4. Shah K, Nakafeero J, Kadota JL, Wambi P, Nanyonga G, Kiconco E, Deus A, Sekadde MP, Nabukenya-Mudiope MG, Tukamuhebwa HA, Mupere E, Mohanty S, Cattamanchi A, Wobudeya E, Shete PB, Jaganath D. The socioeconomic burden of pediatric tuberculosis and role of child-sensitive social protection. BMC public health 2023. PMID: 38007477


  5. Shete PB, Kadota JL, Nanyunja G, Namale C, Nalugwa T, Oyuku D, Turyahabwe S, Kiwanuka N, Cattamanchi A, Katamba A. Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial. ERJ open research 2023. PMID: 37342088


  6. Shete PB, Tang AS, Flood J. Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination. JAMA 2023. PMID: 37129665


  7. Hudson M, Todd H, Nalugwa T, Boccia D, Wingfield T, Shete PB. The impact of social protection interventions on treatment and socioeconomic outcomes of people with tuberculosis and their households: Protocol for a systematic review and meta-analysis. Wellcome Open Research 2023. PMID: 37744729


  8. Schraufnagel AM, Shete PB. Evaluating Social Protection Policies With an Implementation Science Framework: India's Direct Benefit Transfer for Tuberculosis Comment on "Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? - A Mixed-Methods Study on the Need International journal of health policy and management 2023. PMID: 37579424


  9. Todd H, Hudson M, Grolmusova N, Kazibwe J, Pearman J, Skender K, Tran PB, Boccia D, Shete PB, Wingfield T. Social Protection Interventions for TB-Affected Households: A Scoping Review. The American journal of tropical medicine and hygiene 2023. PMID: 36806490


  10. Reis-Santos B, Locatelli R, Oliosi J, Sales CM, do Prado TN, Shete PB, Riley LW, Maciel EL. A Matter of Inclusion: A Cluster-Randomized Trial to Access the Effect of Food Vouchers Versus Traditional Treatment on Tuberculosis Outcomes in Brazil. The American journal of tropical medicine and hygiene 2022. PMID: 36375455


  11. Maya S, McCorvie R, Jacobson K, Shete PB, Bardach N, Kahn JG. COVID-19 Testing Strategies for K-12 Schools in California: A Cost-Effectiveness Analysis. International journal of environmental research and public health 2022. PMID: 35954728


  12. Chapman LAC, Shukla P, Rodríguez-Barraquer I, Shete PB, León TM, Bibbins-Domingo K, Rutherford GW, Schechter R, Lo NC. Risk factor targeting for vaccine prioritization during the COVID-19 pandemic. 2022. PMID: 35197495


  13. Nalugwa T, Handley M, Shete P, Ojok C, Nantale M, Reza T, Katamba A, Cattamanchi A, Ackerman S. Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda. 2022. PMID: 35109936


  14. Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The health and economic benefits of tests that predict future progression to tuberculosis disease. 2021. PMID: 34669631


  15. Cattamanchi A, Reza TF, Nalugwa T, Adams K, Nantale M, Oyuku D, Nabwire S, Babirye D, Turyahabwe S, Tucker A, Sohn H, Ferguson O, Thompson R, Shete PB, Handley MA, Ackerman S, Joloba M, Moore DAJ, Davis JL, Dowdy DW, Fielding K, Katamba A. Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. 2021. PMID: 34936740


  16. León TM, Vargo J, Pan ES, Jain S, Shete PB. Nonpharmaceutical Interventions Remain Essential to Reducing Coronavirus Disease 2019 Burden Even in a Well-Vaccinated Society: A Modeling Study. 2021. PMID: 34514021


  17. Thakur N, Lovinsky-Desir S, Appell D, Bime C, Castro L, Celedón JC, Ferreira J, George M, Mageto Y, Mainous Iii AG, Pakhale S, Riekert KA, Roman J, Ruvalcaba E, Sharma S, Shete P, Wisnivesky JP, Holguin F. Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement. American journal of respiratory and critical care medicine 2021. PMID: 34347574


  18. Samuels THA, Shete PB, Ojok C, Nalugwa T, Farr K, Turyahabwe S, Katamba A, Cattamanchi A, Moore DAJ. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda. 2021. PMID: 34270582


  19. Reitsma MB, Claypool AL, Vargo J, Shete PB, McCorvie R, Wheeler WH, Rocha DA, Myers JF, Murray EL, Bregman B, Dominguez DM, Nguyen AD, Porse C, Fritz CL, Jain S, Watt JP, Salomon JA, Goldhaber-Fiebert JD. Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California. 2021. PMID: 33979192


  20. Mirzazadeh A, Kahn JG, Haddad MB, Hill AN, Marks SM, Readhead A, Barry PM, Flood J, Mermin JH, Shete PB. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. Volume 16 of Issue 4. PloS one 2021. PMID: 33793612


  21. Kadota JL, Nabwire S, Nalugwa T, White JS, Cattamanchi A, Katamba A, Shete PB. Patient Perspectives and Willingness to Accept Incentives for Tuberculosis Diagnostic Evaluation in Uganda. 2021. PMID: 33773327


  22. Tucker A, Oyuku D, Nalugwa T, Nantale M, Ferguson O, Farr K, Reza TF, Shete PB, Cattamanchi A, Dowdy DW, Sohn H, Katamba A. Costs along the TB diagnostic pathway in Uganda. 2021. PMID: 33384046


  23. Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. 2020. PMID: 32916062


  24. Kadota JL, Reza TF, Nalugwa T, Kityamuwesi A, Nanyunja G, Kiwanuka N, Shete P, Davis JL, Dowdy D, Turyahabwe S, Katamba A, Cattamanchi A. Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic. 2020. PMID: 33172531


  25. Rupani MP, Cattamanchi A, Shete PB, Vollmer WM, Basu S, Dave JD. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India. 2020. PMID: 33076969


  26. Akl EA, Blazic I, Yaacoub S, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Hitti E, Jafri H, Jin ZY, Kauczor HU, Kawooya M, Kazerooni EA, Ko JP, Mahfouz R, Muglia V, Nyabanda R, Sanchez M, Shete PB, Ulla M, Zheng C, van Deventer E, Perez MDR. Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. Radiology 2020. PMID: 32729811


  27. Chimoyi LA, Lienhardt C, Moodley N, Shete P, Churchyard GJ, Charalambous S. Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review. BMJ global health 2020. PMID: 32636313


  28. Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. Public health reports (Washington, D.C. : 1974) 2020. PMID: 32735191


  29. Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Public health reports (Washington, D.C. : 1974) 2020. PMID: 32735183


  30. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. medRxiv : the preprint server for health sciences 2020. PMID: 32511538


  31. Reza TF, Nalugwa T, Farr K, Nantale M, Oyuku D, Nakaweesa A, Musinguzi J, Vangala M, Shete PB, Tucker A, Ferguson O, Fielding K, Sohn H, Dowdy D, Moore DAJ, Davis JL, Ackerman SL, Handley MA, Katamba A, Cattamanchi A. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB). Implementation science : IS 2020. PMID: 32316993


  32. Shete PB, Gonzales R, Ackerman S, Cattamanchi A, Handley MA. The University of California San Francisco (UCSF) Training Program in Implementation Science: Program Experiences and Outcomes. Frontiers in public health 2020. PMID: 32292773


  33. Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective. BMC health services research 2020. PMID: 32131814


  34. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. American journal of respiratory and critical care medicine 2019. PMID: 31626560


  35. Cattamanchi A, Berger CA, Shete PB, Turyahabwe S, Joloba M, Moore DA, Davis LJ, Katamba A. Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. Journal of clinical tuberculosis and other mycobacterial diseases 2019. PMID: 31879703


  36. Shete PB, Kahn JG. Economic analyses to inform public health decision-making for tuberculosis: the role of understanding implementation. BMC medicine 2019. PMID: 31783754


  37. Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. Journal of clinical tuberculosis and other mycobacterial diseases 2019. PMID: 31720434


  38. Gomes MGM, Oliveira JF, Bertolde A, Ayabina D, Nguyen TA, Maciel EL, Duarte R, Nguyen BH, Shete PB, Lienhardt C. Introducing risk inequality metrics in tuberculosis policy development. Nature communications 2019. PMID: 31171791


  39. Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics (Basel, Switzerland) 2019. PMID: 31151255


  40. Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete PB, Han AH, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up. Journal of clinical tuberculosis and other mycobacterial diseases 2019. PMID: 31720425


  41. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model. PloS one 2019. PMID: 30964878


  42. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet (London, England) 2019. PMID: 30904263


  43. Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC infectious diseases 2019. PMID: 30890135


  44. Reis-Santos B, Shete P, Bertolde A, Sales CM, Sanchez MN, Arakaki-Sanchez D, Andrade KB, Gomes MGM, Boccia D, Lienhardt C, Maciel EL. Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates. PloS one 2019. PMID: 30794615


  45. Oliosi JGN, Reis-Santos B, Locatelli RL, Sales CMM, da Silva Filho WG, da Silva KC, Sanchez MN, de Andrade KVF, de Araújo GS, Shete PB, Pereira SM, Riley LW, Lienhardt C, Maciel ELN. Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. The Lancet. Global health 2018. PMID: 30584050


  46. Shete PB, Reid M, Goosby E. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease. The Lancet. Global health 2018. PMID: 30224288


  47. Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C. Defining a migrant-inclusive tuberculosis research agenda to end TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2018. PMID: 29991390


  48. Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, Sanchez M, Maciel E, Rasella D, Shete P, Pedrazzoli D, Houben R, Chang S, Dowdy D. Modelling the impact of social protection on tuberculosis: the S-PROTECT project. BMC public health 2018. PMID: 29940906


  49. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2018. PMID: 29663958


  50. Shete PB, Dowdy DW. Measuring success: The challenge of social protection in helping eliminate tuberculosis. PLoS medicine 2017. PMID: 29112688


  51. Sismanidis C, Shete PB, Lienhardt C, Floyd K, Raviglione M. Harnessing the Power of Data to Guide Local Action and End Tuberculosis. The Journal of infectious diseases 2017. PMID: 29117345


  52. Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda. Volume 12 of Issue 8. PloS one 2017. PMID: 28767658


  53. Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017. PMID: 28633698


  54. Shete PB, Haguma P, Miller CR, Ochom E, Ayakaka I, Davis JL, Dowdy DW, Hopewell P, Katamba A, Cattamanchi A. Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2015. PMID: 26162356


  55. Satyanarayana S, Subbaraman R, Shete P, Gore G, Das J, Cattamanchi A, Mayer K, Menzies D, Harries AD, Hopewell P, Pai M. Quality of tuberculosis care in India: a systematic review. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2015. PMID: 26056098


  56. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. The International journal on drug policy 2007. PMID: 17854732


  57. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Molecular and cellular neurosciences 2006. PMID: 16858776


  58. . Erratum to “A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex” [Mol. Cell. Neurosci. 30 (2005) 538–551]. 2006. PMID:


  59. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Molecular and cellular neurosciences 2005. PMID: 16188453


  60. Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Pediatrics 2003. PMID: 12728067


  61. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sexually transmitted diseases 2002. PMID: 12438901


  62. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. The Journal of infectious diseases 2002. PMID: 12195353


  63. Shete PB, Daum RS. Real versus theoretical: assessing the risks and benefits of postponing the hepatitis B vaccine birth dose. Pediatrics 2002. PMID: 11927717